Literature DB >> 14767607

[Laryngeal epithelial dysplasia vs. laryngeal intraepithelial neoplasia].

T Dreyer1, H Glanz.   

Abstract

Laryngeal cancer is the most frequent malignancy of the upper respiratory tract. Only the very early treatment of tumors or even of their precursor lesions will be both curative and organ preserving. Microsurgical techniques facilitate early detection and complete removal of limited lesions can be achieved quite frequently, but follow-up data for such lesions are difficult to obtain. The resulting lack of endpoint observations (i.e., malignant transformation, spontaneous involution) hampers the development, testing, and application of grading systems focusing on epithelial alterations, especially changes with only mild nuclear atypia and minimal structural alteration. Such lesions may be entirely benign or may indicate premalignant stages of well-differentiated carcinoma. For diagnosis we recommend a modified Kleinsasser's system to classify premalignant epithelial changes. Only the complete removal of suspicious lesions as far as possible or regular clinical follow-up in cases where complete removal cannot be achieved can prevent the development of advanced stage cancer.

Entities:  

Mesh:

Year:  2004        PMID: 14767607     DOI: 10.1007/s00292-003-0667-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  25 in total

1.  Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study.

Authors:  R Talamini; C Bosetti; C La Vecchia; L Dal Maso; F Levi; E Bidoli; E Negri; C Pasche; S Vaccarella; L Barzan; S Franceschi
Journal:  Cancer Causes Control       Date:  2002-12       Impact factor: 2.506

2.  [Laryngomicroscopy (lens laryngoscopy) and its importance in the diagnosis of premorbid diseases and early forms of carcinoma of the labium vocale].

Authors:  O KLEINSASSER
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1962

3.  Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis.

Authors:  J D Crissman; R J Zarbo
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-02

4.  [Carcinoma-in-situ of the larynx. Clinical picture and pathology].

Authors:  L B Seiferth; H Glanz
Journal:  Z Laryngol Rhinol Otol       Date:  1971-12

Review 5.  [Early diagnosis and prevention of malignant tumors in the head and neck region].

Authors:  I B Tan; J L Roodenburg; M P Copper; J W Coebergh; I van der Waal
Journal:  Ned Tijdschr Geneeskd       Date:  2001-03-24

6.  [Endoscopic imaging techniques in the diagnosis of laryngeal carcinoma and its precursor lesions].

Authors:  C Arens; K Malzahn; O Dias; M Andrea; H Glanz
Journal:  Laryngorhinootologie       Date:  1999-12       Impact factor: 1.057

7.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

8.  Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies.

Authors:  I F San Francisco; A F Olumi; J Kao; S Rosen; W C DeWolf
Journal:  BJU Int       Date:  2003-03       Impact factor: 5.588

9.  Squamous cell carcinoma in HIV-positive patients under age 45.

Authors:  J T Roland; S G Rothstein; K R Mittal; M S Perksy
Journal:  Laryngoscope       Date:  1993-05       Impact factor: 3.325

10.  Risk factors for laryngeal cancer.

Authors:  E De Stefani; P Correa; F Oreggia; J Leiva; S Rivero; G Fernandez; H Deneo-Pellegrini; D Zavala; E Fontham
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

View more
  2 in total

Review 1.  [Narrow band imaging for evaluation of laryngeal mucosal lesions].

Authors:  N Davaris; S Voigt-Zimmermann; A Roessner; C Arens
Journal:  HNO       Date:  2017-06       Impact factor: 1.284

Review 2.  [Significance of frozen section diagnosis for the management of laryngeal tumors].

Authors:  T Dreyer; B Etschmann; T Kroll; A Bräuninger; S Gattenlöhner; A Benz
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.